InspireMD NSPR Insider Ownership

Updated Oct 9, 2026

Over the trailing 12 months, NSPR insiders bought $425,039 worth of shares (352.48K shares) and sold $99,331 worth (61.19K shares) in open-market trades.

• A count shows 4 insiders buying NSPR stock on the open market over the past 12 months and one insider selling.
• Among InspireMD's insiders, Paul Stuka (Director) was the largest open-market buyer over the past 12 months, purchasing $191,002 of stock (152.23K shares), most recently on May 27, 2026.
• Meanwhile, the largest open-market sales of NSPR in the past 12 months were by Shane Thomas Gleason (Chief Commercial Officer), totaling $99,331 (61.19K shares), most recently on February 2, 2026.
• Away from the open market, NSPR insiders received 999.8K shares in stock awards over the last 12 months.
• Business Quant data puts insider holdings in NSPR at 11.48Mn shares across insiders' latest Form 4 filings, unchanged from 11.48Mn shares at the end of Q2 2026.
• InspireMD insiders hold 10.81Mn shares directly (94.18% of their total) and 668.7K shares (5.82%) indirectly, through entities such as trusts and partnerships.
• Per Business Quant, 14 insiders of NSPR hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
• NSPR's largest insider holders by reported holdings are Marvin Slosman (CEO and President, 3.56Mn shares), Shane Thomas Gleason (Chief Commercial Officer, 1.14Mn shares) and Craig Shore (CFO and CAO, 1.11Mn shares).
• The holding of Marvin Slosman makes up 30.97% of all shares held by InspireMD insiders.
• Institutions accounted for 25.43% of NSPR's outstanding shares in Q2 2026, insiders about 13.56% per their latest Form 4 filings, and other investors, including the public, about 61.01%.
• In the past year, 11 insiders of InspireMD submitted 27 Form 4 filings reporting trades, awards or other transactions.
• This summary of InspireMD insider activity covers Form 4 filings through September 23, 2026.